| 000 | 01051 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513032905.0 | ||
| 264 | 0 | _c19951221 | |
| 008 | 199512s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/0959-8049(95)00034-g _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTreuner, J | |
| 245 | 0 | 0 |
_aNeuroblastoma mass screening: the arguments for and against. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c1995 |
||
| 300 |
_a565-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 | _aGenetic Markers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMass Screening |
| 650 | 0 | 4 |
_aNeuroblastoma _xepidemiology |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aProto-Oncogene Mas |
| 700 | 1 | _aSchilling, F H | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 31A _gno. 4 _gp. 565-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0959-8049(95)00034-g _zAvailable from publisher's website |
| 999 |
_c7576424 _d7576424 |
||